Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Compugen (CGEN) EBITDA (2016 - 2025)

Historic EBITDA for Compugen (CGEN) over the last 15 years, with Q3 2025 value amounting to -$7.9 million.

  • Compugen's EBITDA fell 27555.6% to -$7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$32.2 million, marking a year-over-year decrease of 40446.29%. This contributed to the annual value of -$14.9 million for FY2024, which is 1461.67% down from last year.
  • According to the latest figures from Q3 2025, Compugen's EBITDA is -$7.9 million, which was down 27555.6% from -$25.2 million recorded in Q2 2025.
  • Compugen's EBITDA's 5-year high stood at $18.0 million during Q4 2023, with a 5-year trough of -$30.5 million in Q2 2023.
  • Over the past 5 years, Compugen's median EBITDA value was -$7.9 million (recorded in 2025), while the average stood at -$6.1 million.
  • In the last 5 years, Compugen's EBITDA soared by 60960.61% in 2023 and then plummeted by 27555.6% in 2025.
  • Compugen's EBITDA (Quarter) stood at -$6.3 million in 2021, then skyrocketed by 44.28% to -$3.5 million in 2022, then soared by 609.61% to $18.0 million in 2023, then tumbled by 141.61% to -$7.5 million in 2024, then dropped by 5.48% to -$7.9 million in 2025.
  • Its last three reported values are -$7.9 million in Q3 2025, -$25.2 million for Q2 2025, and $8.4 million during Q1 2025.